Insight 2811’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Insight 2811's ABBV Position: Q3 2026 in Review
Insight 2811 increased its AbbVie (ABBV) stake by 2.7% in Q3 2026, buying an estimated $15.4K and bringing the position to 2,272 shares worth $594K. The position accounts for 0.24% of the portfolio, ranked #57.
Insight 2811 first reported a position in ABBV in Q2 2013 and has held it in 19 quarters since. The position peaked at $688K in Q1 2024. 3,877 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Insight 2811 held 2,272 shares of AbbVie worth $594K as of Q3 2026.
- Insight 2811 bought 60 AbbVie shares in Q3 2026, an estimated $15.4K.
- AbbVie made up 0.24% of Insight 2811's portfolio in Q3 2026, its #57 holding.
- Insight 2811 first reported a position in AbbVie in Q2 2013 and has held it in 19 quarters since.
- Insight 2811's AbbVie position peaked at $688K in Q1 2024.
- 3,877 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Insight 2811's 13F filing for Q3 2026, filed 6 Nov 2026.